
IndraLab
Statements
Hydroxychloroquine inhibits viral life cycle. 28 / 28
|
28
eidos
"1 This may be because both CQ and HCQ have been postulated to reduce viral replication in other coronavirus infections.2 ,3 According to a recent systematic review , there are almost 20 ongoing randomized controlled clinical trials on both medications for treatment of COVID-19 and all of them are in China ."
eidos
"49 In a Syrian hamster model that allows SARS-CoV-2 replication to high titers in the lung leading to bronchopneumonia and lung inflammation , HCQ mildly reduced viral replication in the lungs , but this did not lead to any reduction in lung pathology.50 HCQ treatment did not protect hamsters from contracting the virus from close contact with another infected hamster and did not reduce resulting viral titers.50 CQ also inhibits other coronaviruses ."
eidos
"In this context , it has been proposed that the clinically approved serine protease inhibitor camostat mesylate might decrease SARS-CoV-2 entry in vitro.11 Clinical trials testing of the effect of camostat on COVID-19 are now ongoing ( NCT04321096 ) ; ( b ) use of chloroquine / hydroxychloroquine do inhibit viral replication , as demonstrated in different preclinical models ."
eidos
"Studies performed in vitro showed that chloroquine and hydroxychloroquine both decreased the viral replications in a dose-dependent manner when given at treatment dosing , however the inhibition rate was much lower when pretreated with hydroxychloroquine and chloroquine suggesting less of an effect if given as prophylaxis prior to infection [ 16 ] ."
| PMC
eidos
"In summary , while protease inhibitors may decrease viral burden , inhaled nitric oxide may reduce V / Q mismatch , anticytokine therapy may treat cytokine storm or prevent its progression , and immunomodulators like chloroquine / hydroxychloroquine may inhibit viral replication , RRx-001 may serve as an all-in-one therapy , which improves cardiopulmonary function , decreases viral burden and reduces the systemic inflammatory response ."
| PMC
eidos
"Effects of chloroquine in combination with other antiretrovirals As chloroquine / hydroxychloroquine probably inhibits viral replication by a mechanism different from those of currently used antiretroviral drugs , its application has been studied in combination with other antiretroviral drugs ."